| SC 13G | 2023-04-06 | Park West Asset Management LLC | PLx Pharma Inc. | 1,437,249 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-14 | MSD Partners, L.P. | PLx Pharma Inc. | 686,685 | 2.4% | EDGAR |
| SC 13G/A | 2022-02-16 | WHITE ROCK CAPITAL MANAGEMENT LP | PLx Pharma Inc. | 2,786,900 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Rosalind Advisors, Inc. | PLx Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | Level One Partners, LLC | PLx Pharma Inc. | - | 10.1% | EDGAR |
| SC 13D/A | 2021-06-11 | Park West Asset Management LLC | PLx Pharma Inc. | 2,388,475 | 9.9% | EDGAR |
| SC 13G | 2021-03-16 | Level One Partners, LLC | PLx Pharma Inc. | - | 12.7% | EDGAR |
| SC 13G/A | 2021-01-22 | Rosalind Advisors, Inc. | PLx Pharma Inc. | 970,425 | 6.7% | EDGAR |
| SC 13G | 2020-12-18 | Rosalind Advisors, Inc. | PLx Pharma Inc. | 970,425 | 6.7% | EDGAR |
| SC 13G | 2020-12-16 | WHITE ROCK CAPITAL MANAGEMENT LP | PLx Pharma Inc. | 1,398,219 | 10.0% | EDGAR |
| SC 13G | 2020-05-26 | MSD Partners, L.P. | PLx Pharma Inc. | 645,161 | 6.6% | EDGAR |
| SC 13D/A | 2020-05-20 | Park West Asset Management LLC | PLx Pharma Inc. | 1,473,218 | 16.1% | EDGAR |
| SC 13D/A | 2019-03-01 | Park West Asset Management LLC | PLx Pharma Inc. | 1,473,218 | 16.8% | EDGAR |
| SC 13D/A | 2018-12-31 | Park West Asset Management LLC | PLx Pharma Inc. | 1,473,218 | 16.9% | EDGAR |
| SC 13D | 2017-11-20 | Park West Asset Management LLC | PLx Pharma Inc. | 1,075,723 | 12.3% | EDGAR |
| SC 13G/A | 2017-06-22 | ZIMMERMAN RONALD | PLx Pharma Inc. | 384,681 | 4.4% | EDGAR |
| SC 13G | 2017-06-19 | Park West Asset Management LLC | PLx Pharma Inc. | 1,075,723 | 12.4% | EDGAR |
| SC 13G | 2017-05-01 | ZIMMERMAN RONALD | PLx Pharma Inc. | 377,408 | 6.1% | EDGAR |
| SC 13G/A | 2017-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Dipexium Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Tourbillon Capital Partners, L.P. | Dipexium Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |